McKesson (MCK) NDR Confirms a CRO Deal is NOT on the Table - UBS
Tweet Send to a Friend
UBS analyst Kevin Caliendo reiterated a Buy rating and $205.00 price target on McKesson (NYSE: MCK) after hosting CFO, Britt ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
